Dimerix Ltd (DXB) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Dimerix Ltd (DXB) has a cash flow conversion efficiency ratio of 3.087x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$41.30 Million ≈ $29.22 Million USD) by net assets (AU$13.38 Million ≈ $9.47 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Dimerix Ltd for the company's overall valuation and market capitalisation.
Dimerix Ltd - Cash Flow Conversion Efficiency Trend (1992–2025)
This chart illustrates how Dimerix Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Dimerix Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Dimerix Ltd ranked by their cash flow conversion efficiency. Explore DXB cash to earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Kluang Rubber Company Malaya
KLSE:2453
|
-0.001x |
|
SANTA ANA GLOBAL ENTERPRISES, S
MC:STNA
|
N/A |
|
EA Technique M Bhd
KLSE:5259
|
0.067x |
|
UNICOMMERCE ESOLUTIONS LIMITED
NSE:UNIECOM
|
0.154x |
|
Hana Pharm Co Ltd
KO:293480
|
0.021x |
|
Resource Mining Corporation Ltd
AU:RMI
|
-0.078x |
|
Y.C.C. Parts MFG Co Ltd
TW:1339
|
0.041x |
|
Hauman Technologies
TWO:6218
|
-0.008x |
Annual Cash Flow Conversion Efficiency for Dimerix Ltd (1992–2025)
The table below shows the annual cash flow conversion efficiency of Dimerix Ltd from 1992 to 2025. View DXB share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$13.38 Million ≈ $9.47 Million |
AU$39.05 Million ≈ $27.63 Million |
2.919x | +857.87% |
| 2024-06-30 | AU$18.19 Million ≈ $12.87 Million |
AU$-7.00 Million ≈ $-4.96 Million |
-0.385x | +81.96% |
| 2023-06-30 | AU$5.96 Million ≈ $4.22 Million |
AU$-12.73 Million ≈ $-9.01 Million |
-2.135x | -129.17% |
| 2022-06-30 | AU$14.42 Million ≈ $10.20 Million |
AU$-13.44 Million ≈ $-9.51 Million |
-0.932x | +78.83% |
| 2021-06-30 | AU$1.47 Million ≈ $1.04 Million |
AU$-6.46 Million ≈ $-4.57 Million |
-4.401x | -623.25% |
| 2020-06-30 | AU$7.76 Million ≈ $5.49 Million |
AU$-4.72 Million ≈ $-3.34 Million |
-0.608x | +7.03% |
| 2019-06-30 | AU$4.20 Million ≈ $2.97 Million |
AU$-2.75 Million ≈ $-1.95 Million |
-0.655x | -39.16% |
| 2018-06-30 | AU$6.86 Million ≈ $4.85 Million |
AU$-3.23 Million ≈ $-2.28 Million |
-0.470x | +33.66% |
| 2017-06-30 | AU$2.63 Million ≈ $1.86 Million |
AU$-1.86 Million ≈ $-1.32 Million |
-0.709x | -15.29% |
| 2016-06-30 | AU$2.24 Million ≈ $1.59 Million |
AU$-1.38 Million ≈ $-975.82K |
-0.615x | -205.76% |
| 2015-06-30 | AU$2.78 Million ≈ $1.96 Million |
AU$-558.55K ≈ $-395.21K |
-0.201x | +58.31% |
| 2014-06-30 | AU$1.18 Million ≈ $834.33K |
AU$-568.88K ≈ $-402.52K |
-0.482x | +97.30% |
| 2014-04-30 | AU$31.22K ≈ $22.09K |
AU$-558.55K ≈ $-395.21K |
-17.893x | -9885.60% |
| 2013-06-30 | AU$1.71 Million ≈ $1.21 Million |
AU$-305.90K ≈ $-216.44K |
-0.179x | +9.01% |
| 2012-06-30 | AU$1.18 Million ≈ $834.76K |
AU$-232.33K ≈ $-164.39K |
-0.197x | +5.57% |
| 2011-06-30 | AU$1.57 Million ≈ $1.11 Million |
AU$-326.54K ≈ $-231.04K |
-0.209x | +12.93% |
| 2010-06-30 | AU$1.56 Million ≈ $1.10 Million |
AU$-373.67K ≈ $-264.39K |
-0.240x | +95.32% |
| 2009-06-30 | AU$341.98K ≈ $241.97K |
AU$-1.75 Million ≈ $-1.24 Million |
-5.113x | -114.66% |
| 2008-06-30 | AU$1.01 Million ≈ $713.34K |
AU$-2.40 Million ≈ $-1.70 Million |
-2.382x | -103.42% |
| 2007-06-30 | AU$1.41 Million ≈ $1.00 Million |
AU$-1.66 Million ≈ $-1.17 Million |
-1.171x | -56.68% |
| 2006-06-30 | AU$2.69 Million ≈ $1.91 Million |
AU$-2.01 Million ≈ $-1.42 Million |
-0.747x | -405.76% |
| 2005-06-30 | AU$10.28 Million ≈ $7.27 Million |
AU$-1.52 Million ≈ $-1.07 Million |
-0.148x | -102.79% |
| 2004-06-30 | AU$-170.38K ≈ $-120.55K |
AU$-902.37K ≈ $-638.48K |
5.296x | +422.93% |
| 2003-06-30 | AU$-565.02K ≈ $-399.79K |
AU$-572.26K ≈ $-404.91K |
1.013x | +147.45% |
| 2002-06-30 | AU$282.89K ≈ $200.16K |
AU$-603.82K ≈ $-427.24K |
-2.135x | -1434.07% |
| 2001-06-30 | AU$640.43K ≈ $453.14K |
AU$102.47K ≈ $72.50K |
0.160x | +74.25% |
| 2000-06-30 | AU$5.24 Million ≈ $3.71 Million |
AU$481.16K ≈ $340.45K |
0.092x | -48.60% |
| 1999-06-30 | AU$5.77 Million ≈ $4.08 Million |
AU$1.03 Million ≈ $729.49K |
0.179x | +303.76% |
| 1997-06-30 | AU$1.96 Million ≈ $1.39 Million |
AU$-171.60K ≈ $-121.42K |
-0.088x | -29.69% |
| 1996-06-30 | AU$1.85 Million ≈ $1.31 Million |
AU$-125.03K ≈ $-88.47K |
-0.068x | +5.26% |
| 1995-06-30 | AU$1.72 Million ≈ $1.22 Million |
AU$-123.00K ≈ $-87.03K |
-0.071x | -16.09% |
| 1994-06-30 | AU$1.74 Million ≈ $1.23 Million |
AU$-107.00K ≈ $-75.71K |
-0.061x | -147.59% |
| 1993-06-30 | AU$1.41 Million ≈ $997.66K |
AU$-35.00K ≈ $-24.76K |
-0.025x | -299.35% |
| 1992-06-30 | AU$1.04 Million ≈ $738.70K |
AU$13.00K ≈ $9.20K |
0.012x | -- |
About Dimerix Ltd
Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia. It develops DMX-200 for the treatment of focal segmental glomerulosclerosis disease, diabetic kidney disease, and ARDS associated with COVID-19; and DMX-700 for orphan respiratory/renal disease, as well as proprietary Receptor-HIT assay technology. The company is… Read more